Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

24,298 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A comprehensive analysis of the efficacy and safety of COVID-19 vaccines.
Cai C, Peng Y, Shen E, Huang Q, Chen Y, Liu P, Guo C, Feng Z, Gao L, Zhang X, Gao Y, Liu Y, Han Y, Zeng S, Shen H. Cai C, et al. Among authors: liu y, liu p. Mol Ther. 2021 Sep 1;29(9):2794-2805. doi: 10.1016/j.ymthe.2021.08.001. Epub 2021 Aug 6. Mol Ther. 2021. PMID: 34365034 Free PMC article.
Identification of tumour immune infiltration-associated snoRNAs (TIIsno) for predicting prognosis and immune landscape in patients with colon cancer via a TIIsno score model.
Cai C, Peng Y, Shen E, Wan R, Gao L, Gao Y, Zhou Y, Huang Q, Chen Y, Liu P, Guo C, Feng Z, Zhang X, Liu Y, Shen H, Zeng S, Han Y. Cai C, et al. Among authors: liu y, liu p. EBioMedicine. 2022 Feb;76:103866. doi: 10.1016/j.ebiom.2022.103866. Epub 2022 Feb 7. EBioMedicine. 2022. PMID: 35144219 Free PMC article.
Prognostic stratification based on m5C regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.
Liu P, Zhu Z, Ma J, Wei L, Han Y, Shen E, Tan X, Chen Y, Cai C, Guo C, Peng Y, Gao Y, Liu Y, Huang Q, Gao L, Li Y, Jiang Z, Wu W, Liu Y, Zeng S, Li W, Feng Z, Shen H. Liu P, et al. Among authors: liu y. Front Immunol. 2022 Sep 9;13:951529. doi: 10.3389/fimmu.2022.951529. eCollection 2022. Front Immunol. 2022. PMID: 36159831 Free PMC article.
The optimal first-line treatment for patients with left-sided RAS wild-type metastatic colorectal cancer: Double-drug regimen or triple-drug regimen therapy.
Cai C, Luo Q, Liu Y, Peng Y, Zhang X, Jiang Z, Feng Z, Qi Y, Gao Y, Liu Y, Liu P, Chen Y, Guo C, Shen H, Zeng S, Han Y. Cai C, et al. Among authors: liu y, liu p. Front Pharmacol. 2022 Sep 30;13:1015510. doi: 10.3389/fphar.2022.1015510. eCollection 2022. Front Pharmacol. 2022. PMID: 36249804 Free PMC article.
24,298 results
You have reached the last available page of results. Please see the User Guide for more information.